In certain cancer cell lines, reduced expression of TRAIL receptors DR4 and DR5 and/or upregulation of the decoy receptors DcR1 and DcR2 have been defined as the main causes of TRAIL resistance [48]. Here, TNFRSF10B is linked to cancer.